http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2113442-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b51d317764e2f4f1bbcb355b274c8b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16 |
| filingDate | 1993-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e480aefd29ab1bce521fdf40f2f2573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb47e40568b12433d86f9b2a86cf009b |
| publicationDate | 1998-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2113442-C1 |
| titleOfInvention | Purified derivatives of sulfoalkyl ethers of cyclodextrine or their mixture, clatrate complex of cyclodextrine derivatives with medicinal, and pharmaceutical composition |
| abstract | FIELD: chemistry of complex compounds; production of pharmaceutical compositions. SUBSTANCE: derivatives of cyclodextrine have formula where n=4,5,6, each of R 1 -R 9 is independently O - or O-(C 2-6 -alkylene)--SO - 3 and at least one of R 1 and R 2 is independently mentioned above O-(C 2-6 -alkylene)-SO - 3 group and S 1 -S 9 independently are pharmaceutically acceptable cations. Said derivatives comprise C 2-6 -sulfoalkyl groups, their quantity being from 1 to (3n+6) per each molecule of cyclodextrine; content of underivated cyclodextrine being more than 5 mass % and less than 50 mass %. Clatrate complex of cyclodextrine with medicinal and pharmaceutical composition on its base are also proposed. Said composition may be used orally. EFFECT: improved quality of desired product. 49 cl, 13 dwg , 8 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2470636-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2572334-C2 |
| priorityDate | 1992-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.